Source: Journal of Proteomics. Unidades: ICB, IQ
Subjects: CICLO CELULAR, NEOPLASIAS MAMÁRIAS
ABNT
RUSSO, Lilian C et al. A Cyclin D2-derived peptide acts on specific cell cycle phases by activating ERK1/2 to cause the death of breast cancer cells. Journal of Proteomics, v. 151, p. 24-32, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.jprot.2016.06.028. Acesso em: 12 set. 2024.APA
Russo, L. C., Araujo, C. B. de, Iwai, L. K., Ferro, E. S., & Forti, F. L. (2017). A Cyclin D2-derived peptide acts on specific cell cycle phases by activating ERK1/2 to cause the death of breast cancer cells. Journal of Proteomics, 151, 24-32. doi:10.1016/j.jprot.2016.06.028NLM
Russo LC, Araujo CB de, Iwai LK, Ferro ES, Forti FL. A Cyclin D2-derived peptide acts on specific cell cycle phases by activating ERK1/2 to cause the death of breast cancer cells [Internet]. Journal of Proteomics. 2017 ; 151 24-32.[citado 2024 set. 12 ] Available from: https://doi.org/10.1016/j.jprot.2016.06.028Vancouver
Russo LC, Araujo CB de, Iwai LK, Ferro ES, Forti FL. A Cyclin D2-derived peptide acts on specific cell cycle phases by activating ERK1/2 to cause the death of breast cancer cells [Internet]. Journal of Proteomics. 2017 ; 151 24-32.[citado 2024 set. 12 ] Available from: https://doi.org/10.1016/j.jprot.2016.06.028